Author

K. N. Storm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:multiome· 1 Assay:protein structure· 1

Frequent Co-Authors

A. A. Cohen· 2 shared P. J. Bjorkman· 2 shared P. N. Gnanapragasam· 2 shared A. H. Keeble· 1 shared A. Napier· 1 shared A. R. Townsend· 1 shared J. Gilbert-Jaramillo· 1 shared J. R. Keefe· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. A. Cohen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology

R. A. Hills, T. K. Tan, A. A. Cohen, J. R. Keefe, A. H. Keeble, P. N. Gnanapragasam, K. N. Storm, M. L. Hill, S. Liu, J. Gilbert-Jaramillo, M. Afzal, A. Napier, W. S. James, P. J. Bjorkman, A. R. Townsend, M. Howarth

A vaccine candidate with polyprotein antigens displayed on nanocages induces neutralizing antibodies to multiple SARS-like coronaviruses.

bioRxiv · Feb 24, 2023 · PreprintImmunology

ESCRT recruitment to mRNA-encoded SARS-CoV-2 spike induces virus-like particles and enhanced antibody responses

M. A. Hoffmann, Z. Yang, K. E. Huey-Tubman, A. A. Cohen, P. N. Gnanapragasam, L. M. Nakatomi, K. N. Storm, W. J. Moon, P. J. Lin, P. J. Bjorkman

This study develops a vaccine technology using mRNA encoding spike-EABR to generate eVLPs, enhancing antibody and T-cell responses against SARS-CoV-2 variants.

bioRxiv · Dec 26, 2022 · PreprintImmunology